Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Sean Campbell

Orthopaedic Trauma Sacramento, CA Medical Doctor

NPI 1760757090 CMS profile 5700963

4860 Y St Ste 3800, Sacramento, CA 95817

Open in the dashboard

General payments

$71,266

101 records reported · program years 2019–2025

Research payments

$1,749

Paid to them · 16 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$65,300 paid to institutions, not to them · program years 2023–2025

Through program year 2025, Sean Campbell of Sacramento, CA is reported in the CMS Open Payments database as having received $71,266 across 101 general payments and $1,749 in research payments paid to them. Separately, studies naming them as principal investigator received $65,300 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 84th percentile of Orthopaedic Trauma profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $52,507 40
2024 General $12,308 11
2023 General $3,361 17
2023 Research $1,749 16
2022 General $1,987 15
2021 General $288 8
2020 General $384 5
2019 General $431 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sean Campbell
  • Orthopaedic Trauma median
  • Middle half of Orthopaedic Trauma
  • National median

In program year 2025, general payments to Sean Campbell were reported at $52,507. Among 734 Orthopaedic Trauma profiles paid that year, the median was $1,227 and the middle half received between $259 and $7,433.

Show as a table
Year Sean Campbell Orthopaedic Trauma median Middle half National median
2019 $431 $1,475 $264–$6,401 $163
2020 $384 $596 $120–$4,020 $114
2021 $288 $919 $171–$4,697 $132
2022 $1,987 $1,547 $272–$7,240 $149
2023 $3,361 $1,330 $247–$5,875 $160
2024 $12,308 $1,288 $277–$6,797 $164
2025 $52,507 $1,227 $259–$7,433 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Smith+Nephew, Inc. $58,935 49 payments
  2. Synthes GmbH $4,151 9 payments
  3. Xenco Medical LLC $3,150 1 payment
  4. Medical Device Business Services, Inc. $2,772 9 payments
  5. DePuy Synthes Sales Inc. $1,202 16 payments
  6. Stryker Corporation $594 10 payments
  7. Globus Medical, Inc. $245 4 payments
  8. KCI USA, Inc $122 1 payment
  9. Medtronic, Inc. $77 1 payment
  10. Synthes USA Products LLC $17 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $43,678 8 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $11,550 1 payment
  3. Travel and Lodging $9,720 25 payments
  4. Food and Beverage $4,818 66 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $1,500 1 payment
Products named General payments · program years 2019–2025
  1. EVOS $55,173 39 payments
  2. TRIGEN INTERTAN $19,553 18 payments
  3. TRIGEN META-NAIL $17,456 2 payments
  4. SMART TSF $11,550 1 payment
  5. TRIGEN Trauma Plates, Screws, and Nails $11,550 1 payment
  6. EVOS MINI $7,774 2 payments
  7. Salto Talaris Total Ankle Prosthesis $5,644 1 payment
  8. TRIGEN Trauma Plates, Screws, and Nails $3,190 2 payments
  9. XENSILICO $3,150 1 payment
  10. VA-LCP $1,665 6 payments
  11. Other $4,253 47 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Takeda Pharmaceuticals U.S.A., Inc. $1,749 16 payments

Billing to Medicare

Part B · data year 2024 · 75 billing codes

Paid by Medicare

$72,372

Medicare's payments for the services billed

Medicare patients

124

Average age 73

Services billed

262

76 women, 48 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 60%
Osteoporosis 40%
Diabetes 36%
Depression 35%
Ischemic heart disease 33%
Heart failure 26%
Chronic kidney disease 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

117 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Trauma in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record